Synlett 2007(10): 1513-1516  
DOI: 10.1055/s-2007-982544
LETTER
© Georg Thieme Verlag Stuttgart · New York

An Operationally Simple and Efficient Synthesis of Orthogonally Protected l-threo-β-Hydroxyasparagine

Aikomari Guzmán-Martínez, Michael S. VanNieuwenhze*
Department of Chemistry and Biochemistry, University of California at San Diego, 9500 Gilman Drive, La Jolla, CA 92093, USA
Fax: +1(858)8220386; e-Mail: msv@ucsd.edu;
Weitere Informationen

Publikationsverlauf

Received 22 March 2007
Publikationsdatum:
06. Juni 2007 (online)

Abstract

A synthesis of orthogonally protected l-threo-β-hy­droxyasparagine from l-aspartic acid is reported. Iodocyclization of 3-benzoylaminoaspartic acid provided an intermediate oxazoline dicarboxylate that was efficiently hydrolyzed to l-threo-β-hy­droxyaspartic acid. The synthetic route for conversion of the free β-hydroxy-α-amino acid into the target compound is highly efficient and amenable to the preparation of various orthogonally protected asparagine derivatives, on a multigram scale.

    References and Notes

  • 1 Shoji J. Hinoo H. Matsumoto K. Hattori T. Yoshida T. Matsuura S. Kondo E. J. Antibiot.  1988,  41:  713 
  • 2 Kato T. Hinoo H. Terui Y. Kikuchi J. Shoji J. J. Antibiot.  1988,  41:  719 
  • 3 Bonner DP. O’Sullivan JO. Tanaka SK. Clark JM. Whitney RR. J. Antibiot.  1988,  41:  1745 
  • 4 O’Sullivan J. McCullough JE. Tymiak AA. Kirsch DR. Trejo WH. Principe PA. J. Antibiot.  1988,  41:  1740 
  • 5 Tymiak AA. McCormick TJ. Unger SE. J. Org. Chem.  1989,  54:  1149 
  • 6 Maki H. Miura K. Yamano Y. Antimicrob. Agents Chemother.  2001,  45:  1823 
  • 7 Okai H. Izumiya N. Bull. Chem. Soc. Jpn.  1969,  42:  3550 
  • 8 Singerman A. Liwschitz Y. Tetrahedron Lett.  1968,  4733 
  • 9 Cardillo G. Gentilucci L. Tolomelli A. Tomasini C. Synlett  1999,  1727 
  • 10 Cho GY. Ko SY. J. Org. Chem.  1999,  64:  8745 
  • 11 De Angelis M. Campiani G. Tetrahedron Lett.  2004,  45:  2355 
  • 12 Deng J. Hamada Y. Shioiri T. J. Am. Chem. Soc.  1995,  117:  7824 
  • 13 Dudding T. Hafez AM. Taggi AE. Wagerle TR. Lectka T. Org. Lett.  2002,  4:  387 
  • 14 Hanessian S. Vanasse B. Can. J. Chem.  1993,  71:  1401 
  • 15 Tohdo K. Hamada Y. Shioiri T. Synlett  1994,  247 
  • 16 Boger DL. Lee RJ. Bounaud P.-Y. Meier P. J. Org. Chem.  2000,  65:  6770 
  • 17 Hafez AM. Dudding T. Wagerle TG. Shah MH. Taggi AE. Lectka T. J. Org. Chem.  2003,  68:  5819 
  • 18 Liwschitz Y. Singerman A. J. Chem. Soc. C  1967,  1696 
  • 19 Mattingly PG. Miller MJ. Cooper RDG. Daugherty BW. J. Org. Chem.  1983,  48:  3556 
  • 20 Sieber P. Riniker B. Tetrahedron Lett.  1991,  32:  739 
21

l- threo -BocNH-β-OH-Asp(OMe)-OH ( 4): l-threo-β-Hydroxyaspartic acid (1.00 g, 5.41 mmol) was dissolved in a solution of concentrated HCl (0.89 mL, 10.8 mmol) and MeOH (18.0 mL) at 0 °C. The reaction was heated at reflux for 3 h, then cooled to r.t., and concentrated in vacuo. The crude l-threo-β-OH-Asp(OMe)-OH was triturated with Et2O, collected by filtration, and used without further purification in the following reaction. An aqueous solution of 10% Na2CO3 (18.0 mL) was added to l-threo-β-OH-Asp(OMe)-OH and the resulting mixture was cooled in an iced bath. A solution of Boc2O (3.65 g, 16.2 mmol) in dioxane (18.0 mL) was added dropwise to the reaction mixture and the resulting solution was stirred overnight at r.t. After concentration by rotary evaporation, the residue was dissolved in EtOAc (150 mL) and washed with 1 N HCl solution (3 × 100 mL). The organic layer was separated, dried over Na2SO4, filtered, and concentrated in vacuo. Flash chromatography (SiO2, 35% EtOAc-hexanes followed by 10-25% MeOH-CHCl3) provided 4 (0.88 g, 62%) as a foamy white solid; mp 109-110 °C; [α]23 D +22 (c = 1.00, MeOH). 1H NMR (500 MHz, CD3OD): δ = 4.79 (s, 1 H), 4.50 (s, 1 H), 3.77 (s, 3 H), 1.46 (s, 9 H). 13C NMR (125 MHz, CD3OD): δ = 174.2, 170.2, 155.1, 80.4, 73.0, 59.0, 52.8, 28.7. IR (film): 3388, 2981, 2934, 2858, 1739, 1699, 1608, 1512, 1393, 1367, 1251, 1167, 1107, 1061 cm-1. HR-EI-MS: m/z [M+] calcd for C10H17O7N: 263.1000; found: 263.1001.
l- threo -BocNH-β-OH-Asn ( 5): A sample of l-threo-BocNH-β-OH-Asp(OMe)-OH (4; 1.30 g, 4.94 mmol) was dissolved in MeOH (16.5 mL) and treated with NH3 gas until the solution became saturated. The resulting mixture was stirred at r.t. for 3 d. The reaction was concentrated by rotary evaporation and the crude material was purified by flash chromatography (SiO2, 25% → 50% MeOH-CHCl3), which provided 5 (1.10 g, 90%) as a crystalline solid; mp 165-166 °C; [α]23 D -11 (c = 1.0, MeOH). 1H NMR (400 MHz, CD3OD): δ = 4.63 (s, 1 H), 4.48 (s, 1 H), 1.40 (s, 9 H). 13C NMR (125 MHz, CD3OD): δ = 177.8, 177.7, 157.6, 80.4, 73.6, 59.4, 28.8. IR (KBr): 3369, 2980, 2933, 1694, 1602, 1510, 1395, 1251, 1168, 1109, 1102, 1059, 1029 cm-1. HR-EI-MS: m/z [M+] calcd for C9H16O6N2: 249.1003; found: 249.1002.
l- threo -BocNH-β-OH-Asn-OBn ( 6): A solution of l-threo-BocNH-β-OH-Asn (5; 0.910 g, 3.67 mmol) in DMF (18.3 mL) at 0 °C was treated with NaHCO3 (0.616 g, 7.33 mmol) and benzyl bromide (1.74 mL, 14.3 mmol). The resulting solution was stirred at 0 °C for 2 h and then for 24 h at r.t. The solution was cooled to 0 °C and H2O (100 mL) was slowly added. The resulting mixture was extracted with EtOAc (3 × 50 mL). The combined organic extracts were washed with H2O (100 mL). The organic layer was dried over Na2SO4 and concentrated in vacuo. The crude product was purified by flash chromatography (SiO2, 0% → 5% MeOH-CHCl3), which provided 6 (1.06 g, 86%) as a crystalline solid; mp 135-136 °C; [α]23 D -17 (c = 1.0, CHCl3). 1H NMR (400 MHz, CD3OD): δ = 7.30-7.38 (m, 5 H), 5.19 (s, 2 H), 4.70 (d, J = 2.0 Hz, 1 H), 4.59 (d, J = 2.5 Hz, 1 H), 1.40 (s, 9 H). 13C NMR (125 MHz, CD3OD): δ = 176.2, 171.7, 157.8, 136.9, 129.3, 129.2, 129.0, 128.9, 80.8, 72.7, 68.2, 58.1, 28.7. IR (film): 3358, 2979, 1685, 1653, 1559 cm-1. HR-EI-MS: m/z [M+] calcd for C16H22O6N2: 338.1472; found: 338.1471.
l- threo -FmocNH-β-OH-Asn-OBn ( 7): l-threo-BocNH-β-OH-Asn-OBn (6; 0.740 g, 2.19 mmol) was dissolved in 4 N HCl-dioxane (16.4 mL) and stirred at r.t. for 2 h. The solution was concentrated by rotary evaporation and dried under high vacuum. The residue obtained was dissolved in 50% dioxane-H2O (32.4 mL, 1:1) and the resulting solution was cooled to 0 °C. Fmoc-OSuc (1.14 g, 3.28 mmol) and NaHCO3 (0.368 g, 4.37 mmol) were added to the solution and the resulting mixture was stirred at r.t. for 12 h. The reaction solution was diluted with EtOAc (100 mL) and sat. aq NaHCO3 (150 mL). The aqueous layer was separated and extracted with EtOAc (2 × 75 mL). The combined organic extracts were dried over Na2SO4 and concentrated by rotary evaporation. The crude product was dissolved in the minimal amount of 20% MeOH-CHCl3 solution. Precipitation with hexanes and collection of the solid by filtration provided 7 as a white solid; mp 173-174 °C; [α]23 D -18 (c = 0.80, CHCl3). 1H NMR (400 MHz, CD3OD): δ = 7.78 (d, J = 7.2 Hz, 2 H), 7.64 (d, J = 6.0 Hz, 2 H), 7.26-7.38 (m, 9 H), 5.21 (d, J = 3.2 Hz, 2 H), 4.64 (d, J = 2.4 Hz, 1 H), 4.35 (dd, J = 3.6, 6.0 Hz, 1 H), 4.22 (m, 2 H). 13C NMR (125 MHz, CD3OD): δ = 176.4, 171.7, 158.8, 145.2, 145.1, 142.5, 142.4, 137.0, 129.5, 129.2, 129.1, 128.8, 128.7, 128.2, 128.1, 126.3, 126.2, 120.1, 72.8, 68.4, 68.3, 58.6, 48.2. IR (film): 3328, 1724, 1695, 1655, 1539, 1451, 1299, 1255, 1109 cm-1. HR-EI-MS: m/z [M + H+] calcd for C26H24O6N2: 460.1629; found: 460.1638.
l- threo -FmocNH-β-OH-Asn(Tr)-OBn ( 8): A solution of l-threo-FmocNH-β-OH-Asn-OBn (7; 0.863 g, 1.87 mmol) and Tr-OH (5.05 g, 18.7 mmol) in HOAc (6.52 mL) was heated to 50 °C and treated with concd H2SO4 (65 µL, 1.12 mmol) and Ac2O (0.443 mL, 4.69 mmol). The resulting mixture was stirred at 50 °C for 2.5 h. After cooling to r.t., the reaction solution was diluted with EtOAc (100 mL) and sat. aq NaHCO3 (150 mL). The organic layer was separated and the aqueous layer was extracted with EtOAc (2 × 50 mL). The combined organic layers were dried over Na2SO4 and concentrated in vacuo. Purification by flash chromatography (SiO2, 15% → 30% EtOAc-hexanes) provided 8 (1.03g, 1.46 mmol, 78%) as a white solid; mp 74-75 °C; [α]23 D -14 (c = 0.93, CHCl3). 1H NMR (400 MHz, CD3OD): δ = 7.79 (d, J = 3.2 Hz, 1 H), 7.77 (d, J = 3.2 Hz, 1 H), 7.67 (d, J = 7.6 Hz, 1 H), 7.62 (d, J = 7.2 Hz, 1 H), 7.17-7.38 (m, 24 H), 5.20 (s, 2 H), 4.81 (d, J = 2.0 Hz, 1 H), 4.65 (d, J = 2..0 Hz, 1 H), 4.51 (dd, J = 4.0, 9.6 Hz, 1 H), 4.17 (m, 2 H), 13C NMR (125 MHz, CHCl3): δ = 172.2, 171.8, 158.9, 145.7, 145.3, 145.0, 142.5, 142.4, 137.1, 129.9, 129.7, 129.5, 129.2, 129.0, 128.9, 128.8, 128.7, 128.2, 128.1, 126.5, 126.2, 120.9, 73.4, 71.5, 68.6, 68.3, 58.6, 48.2. IR (film): 3347, 3061, 3022, 2915, 2522, 1723, 1709, 1670, 1493, 1451, 1333, 1218 cm-1. HR-EI-MS: m/z [M+] calcd for C45H38O6N2: 702.2724; found: 702.2721.
l- threo -FmocNH-β-OH-Asn(Tr)-OH ( 2): Pd/C (0.086 g) was cautiously added to a solution of l-threo-FmocNH-β-OH-Asn(Tr)-OBn (8; 0.860 g 1.22 mmol) in EtOH (12.2 mL). The solution was placed under an atmosphere of hydrogen gas for 1 h. The catalyst was removed by filtration through Celite and the filter cake was washed with EtOH. The combined filtrates were concentrated in vacuo and purified by flash chromatography (SiO2, 25% → 50% MeOH-CHCl3), which provided 2 (0.674g, 90%) as a white solid; mp 189-190 °C (dec.); [α]23 D -17 [c = 1.00, MeOH-CHCl3 (1:1)]. 1H NMR (400 MHz, DMSO-d 6): δ = 8.29 (s, 1 H), 7.88 (d, J = 7.5 Hz, 2 H), 7.76 (d, J = 6.5 Hz, 1 H), 7.65 (d, J = 7.0 Hz, 1 H), 7.38 (q, J = 5.0, 7.0 Hz, 2 H), 7.08-7.27 (m, 18 H), 4.52 (d, J = 12 Hz, 1 H), 4.35 (m, 3 H), 4.17 (t, J = 6.5 Hz, 1 H). 13C NMR (DMSO, 125 MHz): δ = 173.8, 171.0, 156.1, 144.7, 143.8, 143.7, 140.7, 128.4, 127.7, 127.1, 126.7, 125.3, 120.1, 72.8, 69.1, 65.8, 57.7, 46.7. IR (KBr): 3387, 3062, 2926, 2857, 1954, 1695, 1601, 1510, 1448, 1404, 1328, 1248, 1106, 1058 cm-1. HR-EI-MS: m/z [M+] calcd for C38H32O6N2: 612.2255; found: 612.2256.